Related Experiment Video
Updated: Jan 9, 2026

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Anti-Parietal Cell Antibodies Show Differential Associations With Stomach Cancer by Site and Helicobacter pylori
Harindra Jayasekara1,2,3, Julie K Bassett1,2, Howard Ho-Fung Tang1
1Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Background:
Autoimmune gastritis poses a risk for stomach cancer. However, its role relative to Helicobacter pylori-associated gastritis is uncertain. We assessed whether the associations between anti-parietal cell antibody (APCA) seropositivity and the risk of stomach cancer and its anatomical subtypes were modified by H. pylori infection.
Materials And Methods:
A total of 244 incident gastric adenocarcinoma cases were identified from the Melbourne Collaborative Cohort Study (N = 41,513) and matched with 448 cancer-free controls using incidence density sampling with age as the time scale, matching on sex, year of birth, and country of birth. IgG antibodies against parietal cells and H. pylori were analyzed using commercially available ELISA kits. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using conditional logistic regression.
Results:
Seropositivity for APCA was 21% for controls and 24% for cases (28% cardia, 23% non-cardia), while seropositivity for H. pylori was 62% for controls and 76% for cases (55% cardia, 81% non-cardia). The following ORs were observed for total, cardia, and non-cardia cancers in relation to APCA seropositivity: 1.21 (95% CI: 0.84-1.76), 1.99 (0.84-4.73), and 1.09 (0.71-1.66), respectively. Stronger associations were observed for cardia cancer in H. pylori-seropositive individuals (ORs, 3.60 [95% CI: 1.07-12.12] vs. 0.93 [0.24-3.57] for H. pylori-seronegative individuals; pinteraction = 0.15) and for non-cardia cancer in H. pylori-seronegative individuals (ORs, 2.56 [1.02-6.40] vs. 0.93 [0.56-1.54] for H. pylori-seropositive individuals; pinteraction = 0.06).
Conclusions:
Our findings suggest a more complex association between autoimmune gastritis and the risk of stomach cancer. They also highlight the importance of early detection of autoimmune gastritis in stomach cancer prevention.
More Related Videos
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...